To determine whether Pten-deficient neoplasia was specifically dependent on the BMP5 ligand, we inactivated both Pten and Bmp5 in KRT5-positive basal cells of the prostate and skin (Figure 4G). The gene discussed is PTEN; the disease is neoplasm.